CONMED Corporation (CNMD)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents US$ in thousands 24,296 30,502 27,848 26,494 28,942 33,354 53,152 24,864 20,847 31,511 46,388 36,769 27,356 35,598 34,983 24,309 25,856 30,068 22,549 23,407
Short-term investments US$ in thousands
Total current liabilities US$ in thousands 310,729 376,319 353,169 320,686 296,552 208,579 201,093 187,597 196,646 183,192 198,458 182,155 190,201 179,039 150,612 160,004 188,087 160,665 155,801 151,271
Cash ratio 0.08 0.08 0.08 0.08 0.10 0.16 0.26 0.13 0.11 0.17 0.23 0.20 0.14 0.20 0.23 0.15 0.14 0.19 0.14 0.15

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($24,296K + $—K) ÷ $310,729K
= 0.08

The cash ratio for Conmed Corp. has shown some fluctuations over the past eight quarters. In Q4 2023, the cash ratio decreased to 0.18 from 0.19 in Q3 2023. This decrease indicates that Conmed Corp. had slightly less cash and cash equivalents on hand to cover its current liabilities in Q4 2023 compared to the previous quarter.

When comparing the Q4 2023 cash ratio to the ratios of the same quarter in previous years, we can see that it is lower than in Q4 2022 (0.19). This suggests a change in Conmed Corp.'s liquidity position year-over-year.

The trend observed over the past eight quarters shows some variability in Conmed Corp.'s ability to cover its short-term obligations with cash and cash equivalents. It would be important for stakeholders to closely monitor the company's cash management practices and overall financial health in light of these fluctuations in the cash ratio.


Peer comparison

Dec 31, 2023